To the study the role of vitamin D3 injection for treating cutaneous warts

Not yet recruiting

Conditions: healthy human volunteers having cutaneous warts

Registration Number: CTRI/2018/05/013908

Lead Sponsor: Dr Shrini Parikh

Brief Summary: To study the role of intralesional vitamin D3 injection as an immunotherapeutic agent in treating cutaneous warts which are previously untreated for the past 6 months in > 18 years of patients

0.2-0.5ml of vitamin D3 will be injected in lesions with a 26-gauge insulin syringe depending on the number of warts in maximum of 5 warts. The injections will be performed at 2 weekly intervals for 4 sessions. The patients will be followed up for a period of 6 months to check for recurrence of warts.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 100

Inclusion Criteria

1 patients having cutaneous warts 2 patients > 18 years 3 patients with no prior treatment with either topical or destructive modalities for atleast 6 months.

Exclusion Criteria

1 patients < 18 years 2 pregnant and lactating females 3 any evidence of immunosuppression including HIV 4 prior history of hypersensitivity to vitamin D3 5 previously diagnosed renal disease.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
regression of cutaneous warts	2 weekly intervals for a maximum of 4 sessions

Secondary Outcome Measures

Name	Time	Method
to prevent recurrence of warts	for upto 6 months after resolution of warts

Trial Locations

Locations (1): Peoples college of medical sciences and research centre
🇮🇳
Bhopal, MADHYA PRADESH, India
Peoples college of medical sciences and research centre
🇮🇳Bhopal, MADHYA PRADESH, India
Dr Shrini Parikh
Principal investigator
90982821100
shrini.parikh@gmail.com